Specificity of the digoxin radioimmunoassay with respect to dihydrodigoxin. 1976

W G Kramer, and M S Bathala, and R H Reuning

An investigation was conducted to determine the specificity of the digoxin antibody provided in a commercially available radioimmunoassay kit with respect to dihydrodigoxin. Over the concentration range of 0.5 to 8.0 ng./ml. dihydrodigoxin displaced the 125I digoxin derivative from the antibody to a degree that could be significant at clinically observed serum and urine digoxin concentrations.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody

Related Publications

W G Kramer, and M S Bathala, and R H Reuning
December 1982, Clinical chemistry,
W G Kramer, and M S Bathala, and R H Reuning
January 1978, Clinical chemistry,
W G Kramer, and M S Bathala, and R H Reuning
April 1982, The Journal of pharmacology and experimental therapeutics,
W G Kramer, and M S Bathala, and R H Reuning
July 1975, Clinica chimica acta; international journal of clinical chemistry,
W G Kramer, and M S Bathala, and R H Reuning
November 1972, Research communications in chemical pathology and pharmacology,
W G Kramer, and M S Bathala, and R H Reuning
June 1978, Clinical chemistry,
W G Kramer, and M S Bathala, and R H Reuning
August 1985, Clinical chemistry,
W G Kramer, and M S Bathala, and R H Reuning
January 1974, Drug metabolism and disposition: the biological fate of chemicals,
W G Kramer, and M S Bathala, and R H Reuning
January 1985, Drug metabolism and disposition: the biological fate of chemicals,
W G Kramer, and M S Bathala, and R H Reuning
June 1986, Applied and environmental microbiology,
Copied contents to your clipboard!